Increased intraepithelial Vα24 invariant NKT cells in the celiac duodenum by Montalvillo, Enrique et al.
Article
Increased Intraepithelial Vα24 Invariant NKT Cells in
the Celiac Duodenum
Enrique Montalvillo 1, David Bernardo 2,3, Beatriz Martínez-Abad 1, Yessica Allegretti 4,
Luis Fernández-Salazar 5, Carmen Calvo 6, Fernando G. Chirdo 4, José A. Garrote 1,7,: and
Eduardo Arranz 1,:,*
Received: 23 July 2015 ; Accepted: 21 October 2015 ; Published: 30 October 2015
1 Mucosal Immunology Lab, IBGM, University of Valladolid-CSIC, Sanz y Forés 3, 47003 Valladolid, Spain;
emontalvillo@gmail.com (E.M.); beamaraba@gmail.com (B.M.A.); jagarrote@saludcastillayleon.es (J.A.G.)
2 Antigen Presentation Research Group, Imperial College London, Northwick Park & St Mark’s Campus,
Level 7W, St Mark's Building Watford Road Harrow HA1 3UJ, UK; d.bernardo.ordiz@gmail.com
3 Gastroenterology Unit, Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria
Princesa (IIS-IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y
Digestivas (CIBEREHD), Madrid 28006, Spain
4 Laboratorio de Investigación en el Sistema Inmune –LISIN, Departamento de Ciencias Biológicas, Facultad
de Ciencias Exactas, Universidad Nacional de La Plata, 115, La Plata 1900, Buenos Aires, Argentina;
yallegretti@gmail.com (Y.A.); fchirdo@biol.unlp.edu.ar (F.G.C.)
5 Gastroenterology Unit, Hospital Clínico Universitario; Ramón y Cajal 3, Valladolid 47005, Spain;
luisfernsal@gmail.com
6 Paediatric Unit, Hospital Clínico Universitario; Ramón y Cajal 3, Valladolid 47005, Spain;
carmencalvoromero@gmail.com
7 Medical Laboratory Service, Hospital Universitario Rio Hortega; Dulzaina 2, Valladolid 47012, Spain
* Correspondence: earranz@med.uva.es; Tel.: +34-983-184-843
: These authors contributed equally to this work.
Abstract: Celiac Disease (CD) is an interferon (IFN)γ-mediated duodenal hypersensitivity to wheat
gluten occurring in genetically predisposed individuals. Gluten-free diet (GFD) leads to a complete
remission of the disease. Vα24-restricted invariant NKT (iNKT) cells are important to maintain
immune homeostasis in the gut mucosa because of their unique capacity to rapidly produce large
quantities of both T-helper (Th)1 and Th2 cytokines upon stimulation. We studied the presence of
these cells in the CD duodenum. Duodenal biopsies were obtained from 45 untreated-CD patients
(uCD), 15 Gluten Free Diet-CD patients (GFD-CD), 44 non-inﬂamed non-CD controls (C-controls)
and 15 inﬂamed non-CD controls (I-controls). Two populations from Spain and Argentina were
recruited. Messenger RNA (mRNA) expression of Vα24-Jα18 (invariant TCRα chain of human iNKT
cells), IFNγ and intracellular transcription factor Forkhead Box P3 (Foxp3), and ﬂow cytometry
intraepithelial lymphocyte (IEL) proﬁle were determined. Both uCD and GFD-CD patients had
higher Vα24-Jα18 mRNA levels than non-CD controls (I and C-controls). The expression of
Vα24-Jα18 correlated with Marsh score for the severity of mucosal lesion and also with increased
mRNA IFNγ levels. uCD and GFD-CD patients had decreased mRNA expression of FoxP3 but
increased expression of Vα24-Jα18, which revealed a CD-like molecular proﬁle. Increased numbers
of iNKT cells were conﬁrmed by ﬂow cytometry within the intraepithelial lymphocyte compartment
of uCD and GFD-CD patients and correlated with Vα24-Jα18 mRNA expression. In conclusion, we
have found an increased number of iNKT cells in the duodenum from both uCD and GFD-CD
patients, irrespective of the mucosal status. A CD-like molecular proﬁle, deﬁned by an increased
mRNA expression of Vα24-Jα18 together with a decreased expression of FoxP3, may represent a
pro-inﬂammatory signature of the CD duodenum.
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1. Introduction
Celiac disease (CD) is an inﬂammatory disorder of the small intestine induced by wheat
gluten and other prolamins from rye, barley and some varieties of oats [1] in genetically
susceptible individuals. It is characterized by an interferon (IFN)-γ mediated type I cytokine
proﬁle [2]. CD manifestation is characterized by an increased number of intraepithelial and lamina
propria lymphocytes, villous atrophy, tissue remodeling and the presence of anti-transglutaminase
antibodies [3]. At present, the only treatment for CD is a life-long strict gluten-free diet (GFD), which
normally leads to a complete remission of the disease [4].
Gut intraepithelial lymphocytes (IEL) comprise a heterogeneous population of cells outside the
normal circulation. In addition to conventional T lymphocytes (CD3` TCRαβ`, either CD4` or
CD8`) with an outstanding CD3` CD8` prevalence, Natural Killer (NK) cells and unconventional
IEL populations such as CD8αα, TCRγδ` cells, CD3`CD4´CD8´ cells and NKT lymphocytes are
widely represented [5,6].
Increased total numbers of IEL CD3` (both classical and TCRγδ`) and decreased IEL non-T cells
(CD3´, CD103`) have been consistently reported in CD [7–9]. A direct cytolytic effect of conventional
CD3`αβ`CD8` cytotoxic IEL on adjacent enterocytes is undisputed [10,11] and related to villous
atrophy [7]. However, the role of IEL TCRγδ` in CD pathogenesis remains elusive, although they
may have a key role in oral tolerance as supported by the identiﬁcation of a subset of regulatory
TCRγδ` IEL population capable of limiting the cytotoxicity of IEL in CD treated on a GFD [12].
Classical regulatory Tcells (Tregs; CD3`, CD4`, CD25` and intracellular transcription factor
Forkhead Box P3` (FoxP3`)) and non-classical interleukin (IL)-10 producing regulatory cells (Tr1:
CD3`, CD4`, CD25´ and intracellular FoxP3´) are the main regulatory T-cells found in the
intestine [13]. Tregs elicit their function by suppressing IL-2 production and T-cell proliferation [14],
while Tr1 cells are the main source of IL-10 in the intestinal lamina propria since they are chronically
stimulated and limit the production of pro-inﬂammatory cytokine by controlling inﬂammatory
responses to dietary antigens. Compared to Tregs, the ﬁnding of larger numbers of Tr1 in the intestinal
lamina propria suggests that these cells have an important regulatory capacity [15,16].
Invariant NKT cells (iNKT; CD3`, TCR Vα24`Vβ11`) are also important to maintain immune
homeostasis [13]. Human iNKT cells express classical NK cell markers as well as an invariant TCRα
chain (iNKTα) (Vα24-Jα18 in humans) paired to “semi-invariant” TCRβ chains (iNKTβ), which
recognizes antigens presented by the major histocompatibility complex (MHC) class I-like molecule
CD1d [17,18]. For all iNKT-cell TCRs, binding to CD1d is primarilymediated by the Vα-Jα rearranged
invariant CDR3α loop [19]. Therefore, the anti-Vα24-Jα18 is the standard method used to detect
human iNKT cells [20,21]. These cells can be sub-divided into CD4` and CD4´ (most of these
CD4´CD8´) cells. CD4´CD8´ iNKT cells produce predominantly T-helper (Th)1 cytokines (IFNγ
and TNFα) whereas CD4` iNKT cells can produce both Th1 and Th2 (IL-4 and IL-13) cytokines [13].
Because of their unique capacity to rapidly produce large quantities of both Th1 (IFNγ) and Th2 (IL-4)
cytokines upon stimulation [22], iNKT cells may have a key role in protection against tumors or in
preventing autoimmune disease [23]. Despite low numbers, iNKT cells have a central role in intestinal
homeostasis [17,24,25] and are essential for the development of oral tolerance [26,27]. Nevertheless,
their number within the intraepithelial and lamina propria compartments and their speciﬁc role in
CD pathogenesis remains elusive.
In this manuscript, we aimed to study whether changes in the number of iNKT cells may
be altered in the duodenum of CD patients. To these aim we assessed the mRNA expression of
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Vα24-Jα18 and the proportion of iNKT cells within the intraepithelial compartment to reveal an
increased number of these cells in the CD mucosa.
2. Materials and Methods
2.1. Patients and Biopsy Samples
Duodenal samples were collected from two independent populations in Spain (Hospital Clínico
Universitario de Valladolid) and Argentina (Biobank from the LISIN, La Plata). The Spanish
population included 25 untreated celiac patients (uCD, mean age 28.9 years; range 5–76 years;
42% males) (Table S1), 15 CD patients treated with GFD (GFD-CD; mean age 34.2 years; range
4-71 years; 34% males) (Table S2), 15 non-CD patients with other inﬂamed conditions (I-controls,
mean age 42.1 years; range 15–78 years; 56% males) (Table S3) and 25 non-inﬂamed non-CD controls
(C-controls; mean age 38.3 years; range 6–81 years; 30%males) (Table S4). TheArgentinian population
included 20 uCD patients (mean age 24.8 years; range 4-56 years; 28% males) (Table S5) and
19 C-controls (mean age 31.4 years; range 6–62 years; 52% males) (Table S6). Regarding age and
gender, no statistically differences were found between Spanish and Argentinian patients. Clinical
data from patient groups included in the study are shown in Table 1. The experiments were conducted
with the understanding and thewritten consent of the adult participants, or the next of kin, caretakers,
or guardians on behalf of the minors/children enrolled in this study. The study and the written
consent procedure were approved by the Ethics committees from Hospital Clínico Universitario of
Valladolid and Biobank from the LISIN, La Plata.















uCD 45 27.1 (4–76) 36% males + + II-III No
GFD-CD 15 34.2 (4–71) 34% males + - II-III Yes
Non Celiac
Patients
I-controls 15 42.1 (15–78) 56% males +/- - (*A) 0-I (M.M) No
C-controls 44 35.3 (6–81) 41% males - (*B) - (*A) 0 No
uCD (untreated celiac patients), GFD-CD (celiac patients treated with gluten free diet), I-controls (non celiac
patients with other inﬂamed conditions) and C-controls (non-celiac disease patients without other inﬂamed
conditions). IgA anti-tTG (Anti-tissue transglutaminase antibodies), EMA (Endomysium antibodies), GFD
(Gluten free diet). M.M (mildmucosal alterations non compatibles with celiac disease). *A Serological test were
performed only in genetically susceptible patients. *B Two patients had positive genetic susceptibility markers.
At diagnosis, all CD patients had CD-compatible symptoms, positive anti-endomysium and/or
anti-transglutaminase IgA antibodies, CD-associated risk alleles (HLA-DQ2 and DQ8), and duodenal
biopsy with histopathological changes. No differences in clinical markers were found between
Spanish and Argentinian CD individuals. Patients on a GFD showed an improvement of the
histological lesion (Marsh 0-I), and negative serum anti-transglutaminase antibodies for at least
one year. Control groups were collected from patients referred to the gastroenterology clinics for
diagnostic investigations due to clinical suspicion of intestinal disease (chronic diarrhea, gastritis by
Helicobacter pylori, hiatus hernia, etc.). Similar symptoms were observed in both populations. Some
of these cases showed duodenal inﬂammation (I-controls) while lack of mucosal affection was found
in C-controls. None of them had a ﬁnal diagnosis of CD.
2.2. Quantitative PCR
Duodenal biopsies from the Spanish (40 CD patients (25 uCD and 15 GFD-CD), 25 C-controls and
15 I-controls) and the Argentinian population (20 uCD and 19 C-controls) were submerged in 0.5 mL
of RNALaterr solution (Ambion Inc, Austin, Texas, USA) and stored at ´20 ˝C immediately after
sample taking. Total RNA was isolated using the TRI-Reagentr Solution according to manufacturer
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instructions (Ambion Inc, Austin, Texas, USA). In parallel, 15 duodenal samples from each group of
patients from the Spanish population were also analyzed by ﬂow cytometry as described below to
determine the phenotype of lymphocytes and iNKT cells.
Reverse transcription was carried out by using the SuperScriptr First-Strand Synthesis System
for reverse transcriptase (RT)-PCR Kit (Applied Biosystems, Carlsbad, CA, USA) with random
hexamers as primers. Reactions were performed using the FastStart SYBR Green MasterMix (Roche
Applied Science, Mannheim, Germany) with thermolabile Uracil DNA Glycosylase to prevent
carry-over contamination. Messenger RNA levels (βactin, IFNγ, Vα24-Jα18 and FoxP3) were
measured by quantitative PCR (qPCR) on a LightCyclerr instrument (Roche Applied Science,
Mannheim, Germany) after extrapolation to an external curve. Primer sets and PCR conditions
are described in Table 2. Levels of mRNA are expressed as the ratio molecule/βactin in arbitrary
units (AU).
Table 2. Primer sequences for quantitative-PCR.
Molecule Primers Sequence NCBI Locus Annealing T
βactin fw: 5
1 - ATG GGT CAG AAG GAT TCC TAT GTG - 31
rv: 51 - CTT CAT GAG GTA GTC AGT CAG GTC - 31 NM_001101.3 60
IFNγ fw: 5
1 - TGG AAA GAG GAG AGT GAC AG - 31
rv: 51 - ATT CAT GTC TTC CTT GAT GG - 31 NM_000619.2 60
Vα24-Jα18 fw: 5
1 - CTG GAG GGA AAG AAC TGC - 31
rv: 51 - TGT CAG GGA AAC AGG ACC - 31 NC_000014.9 65
FoxP3 fw: 5
1 - CAG CAC ATT CCC AGA GTT CCT C - 31
rv: 51 - GCG TGT GAA CCA GTG GTA GAT C - 31 NM_014009.3 60
Primer sequences used for quantitative-PCR. NCBI locus and annealing temperature point (annealing T). IFNγ
(interferon-γ), Vα24-Jα18 (invariant TCRα chain of human iNKT cells), FoxP3 (intracellular transcription factor
Forkhead Box P3).
2.3. Isolation of Intraepithelial Lymphocytes and Lamina Propria Mononuclear Cells
Biopsy samples from 15 uCD, 15 GFD, 15 non-inﬂamed non-CD controls (C-controls) and
15 inﬂamed non-CD controls (I-controls) were collected from the Spanish population. Samples
were kept in ice-chilled physiologic phosphate buffered saline (PBS) and processed within an hour
as previously described [28,29]. Brieﬂy, IEL and epithelial cells were released from the mucosal
specimens by incubation for 1 hour under gentle agitation with 1 mM ethylenediaminetetraacetic
acid (EDTA) and 1 mM dithiothreitol (DTT) in RPMI 1640 medium (GibcoBRL Life Technologies,
Vienna, Austria) supplemented with 10% fetal calf serum, 2mM L-glutamine, 100U/mL penicillin,
100 µg/mL streptomycin and 0.25 µg/mL amphotericin (GibcoBRL Life Technologies, Vienna,
Austria). Following DTT and EDTA incubation IEL were released into the medium and collected
by centrifugation, washed twice in PBS (Lonza, Braine-l’Alleud, Belgium) and stained with
ﬂuorochrome-conjugated monoclonal antibodies (mAbs).
The remaining tissue was incubated in moderated rotation at 37 ˝C for 90–120 min. with
1 mg/mL of collagenase D in RPMI 1640 medium (GibcoBRL Life Technologies, Vienna, Austria)
supplemented with 10% fetal calf serum and antibiotics until the biopsies have been completely
degraded. Single cell suspensions were ﬁltered (70 µm Nylon Filter, BD Biosciences, San Diego, CA,
USA) to remove non-cellular ﬁbers, and the lamina propria mononuclear cells (LPMC) suspension
was washed twice in PBS.
2.4. Antibody Labeling and Flow Cytometry Analysis
A total of 100,000 isolated cells (IEL or LPMC) were labeled with ﬂuorochrome-conjugated
monoclonal antibodies (mAbs) and their appropriate isotype-matched control antibodies from
the same manufacturers. The ﬂuorochrome-conjugated mAbs were: FITC Mouse anti-human
CD103 (clone Ber-ACT8), PE Mouse anti-human Vα24-Jα18 (clone 6B11, speciﬁcally recognizing all
T cells expressing the conserved CDR3 region of the Vα24Jα18 invariant TCRα rearrangement), PE
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Mouse anti-human TCRγδ (clone B1), APC Mouse anti-human CD3 (clone HIT3a), APC Mouse
anti-human CD25 (clone M-A251), PE-Cy7 Mouse anti-human CD8 (clone RPA-T8) and PE-Cy7
Mouse anti-human CD45 (clone HI30) from BD Pharmingen (San Diego, CA, USA); PE Mouse
anti-human FoxP3 (clone PCH101) from eBioscience (San Diego, CA, USA); FITC Mouse anti-human
CD4 (clone 13B8.2) and PE Mouse anti-human CD8 (clone B9.11) from Beckman Coulter (Brea , CA,
USA). Cells were labeled in phosphate-buffered saline containing 1 mM EDTA and 0.02% sodium
azide (ﬂuorescent-activated cell sorting (FACS) buffer). Labeling was performed on ice and in the
dark for 20 min. Cells were washed twice in FACS buffer, ﬁxed with 1% paraformaldehyde in 0.85%
saline, and stored at 4 ˝C before acquisition on the ﬂow cytometer within 24 h. For FoxP3 intracellular
staining, cells were ﬁxed with Leucoperm A following surface staining and permeabilized with
Leucoperm B (Bio-Rad, UK) before adding antibody for intracellular labeling. After incubation cells
were washed in FACS buffer, ﬁxed, and acquired as previously reported.
Cells were acquired in a Beckman Coulter FC500 ﬂow cytometer and data processed with Cell
BC software (Beckman Coulter, Brea, CA, USA). All IEL and lamina propria lymphocyte (LPL) cells
were identiﬁed as CD45` (leukocyte pan-marker) and IELs were also identiﬁed as CD103`. Non-T
cells (CD3´), TCRγδ cells (CD3`TCRγδ`), TCRαβ cells (CD3`TCRγδ´) (Figure 1A), iNKT cells
(CD3`Vα24-Jα18`) (Figure 1B) and Treg cells (CD3`CD4`CD25`FoxP3` or CD3`CD4`FoxP3`)
were identiﬁed by ﬂow cytometry within the intraepithelial and the lamina propria compartments.
Numbers of cells were expressed as percentages.
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Figure  1.  Identification  of  intraepithelial  and  lamina  propria  lymphocytes  by  flow  cytometry. 
Example of characterization of intraepithelial lymphocytes (IELs)/lamina propria lymphocytes (LPL) 
in an untreated celiac disease donor. Lamina propria (CD45+) and IEL (CD45+CD103+) were identified 





Figure 1. Identiﬁcation of intraepithelial and lamina propria lymphocytes by ﬂow
cytometry. Example of characterization of intraepithelial lymphocytes (IELs)/lamina propria
lymphocytes (LPL) in an untreated celiac disease donor. Lamina propria (CD45`) and IEL
(CD45`CD103`) were identiﬁed and percentages of TCRαβ cells, TCRγδ cells and non-T cells
determined (A). Example of characterization of invariant NKT (iNKT) cells in a untreated
celiac disease donor: CD45`CD3`Vα24-Jα18` cells within the total of CD45`CD3` cells, iNKT
(CD45`CD3`Vα24-Jα18`) phenotype according to the expression of CD4 and/or CD8 within the
total of iNKTs (B).
2.5. Statistical Analysis
Correlation analyses and two-tailed non-parametric statistical analyses were performed
using the Kruskal-Wallis one way analysis of variance test, the Mann-Whitney U test and the
non-parametric Spearman’s correlation. p < 0.05 was considered signiﬁcant. Flow cytometry results
were expressed as percentages and analysed by the two-tailed non-parametric Mann-Whitney U test.
p < 0.05 was considered signiﬁcant. Reference values of the IEL subpopulations for each patient’s
group were expressed as median percentages with the interquartile range (IQR).
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3. Results
3.1. Increased Duodenal Vα24-Jα18 mRNA Expression in Celiac Disease Patients
Due to the low numbers of iNKT cells both in blood [21] and tissue samples [22] we ﬁrst
studied the proportion of iNKT cells in duodenal biopsies by assessing the mRNA expression or
their restrictive invariant Vα24-Jα18 chain in complete biopsy explants [20,21].
Untreated-CD patients (uCD) had increased Vα24-Jα18mRNA levels compared to both inﬂamed
non-CD (I-controls) (p < 0.05) and non-inﬂamed non-CD controls (C-controls) (p < 0.001) (Figure 2A).
Gluten Free Diet-CD patients (GFD-CD) had increased Vα24-Jα18 mRNA levels compared to
C-controls (p < 0.001). No differences were found between uCD and GFD-CD patients, which
suggests an increased load of iNKT cells in duodenal biopsies from both groups of patients
irrespectively of the disease status (Figure 2A). We also analyzed duodenal expression of Vα24-Jα18
mRNA in an independent population from Argentina. Figure 2B conﬁrms that CD patients show
increased duodenal Vα24-Jα18 mRNA levels compared to non-inﬂamed non-CD controls (p < 0.001),
irrespectively of the origin of the samples. No statistically signiﬁcant differences in Vα24-Jα18 mRNA
levels were found between the Spanish and the Argentinian populations, neither within the control
nor the untreated CD patient groups.
Samples from GFD-CD patients showed a Marsh score for the severity of the mucosal lesion
between 0 and I, and no differences were found in these sub-groups regarding Vα24-Jα18 mRNA
expression. Untreated CD patients had a Marsh score rating from I to IIIc, and in these patients,
Vα24-Jα18 mRNA levels correlated with the Marsh score (Spearman’s r = 0.063, p < 0.05) (Figure 2C).
3.2. Correlation between Duodenal Vα24-Jα18 and IFNγ mRNA Expression in Celiac Disease
Duodenal samples from CD patients (either treated and untreated) had increased IFNγ mRNA
expression compared with non-inﬂamed non-CD controls both in the Spanish (GFD-CD, p < 0.05;
uCD, p < 0.001) (Figure 3A) and the Argentinian populations (uCD, p < 0.05) (Figure 3B) as
previously described [30,31]. Since both mRNA levels of IFNγ [2,30] and Vα24-Jα18 (Figure 2C)
correlated with the Marsh score for the severity of the mucosal lesion, we studied if the expression
of IFNγ and Vα24-Jα18 was related. A correlation was found between the mRNA levels of IFNγ
and Vα24-Jα18 in treated and untreated CD samples in both the Spanish (C-controls: Spearman’s
r = 0.3115, p value = n.s; I-controls: Spearman’s r = 0.4265, p value = n.s; GFD-CD: Spearman’s
r = 0.5393, p < 0.05; uCD: Spearman’s r = 0.4323, p < 0.05) and the Argentinian populations (C-controls:
Spearman’s r = 0.5895, p < 0.05; uCD: Spearman’s r = 0.6917, p < 0.001) (Figure 3C,D).
3.3. Duodenal Vα24-Jα18 and FoxP3 mRNA Levels Reveal a Celiac Disease Molecular Proﬁle
We next studied FoxP3 mRNA expression in the duodenum as an indirect way of quantifying
Treg cells in tissue. CD samples (both uCD and GFD-CD) had decreased FoxP3 expression compared
with non-inﬂamed non-CD-controls (C-controls) (uCD, p < 0.001; GFD-CD, p < 0.001) (Figure 4A).
Similar results were found on a second independent analysis of the Argentinian population (uCD,
p < 0.001) (Figure 4B). Because CD samples were characterized by increased duodenal mRNA
expression of Vα24-Jα18 (Figure 2A,B) and decreased expression of FoxP3 (Figure 4A,B), we studied
whether the joint analysis of these twomolecules could help us to identify a CD-likemolecular proﬁle.
No differences were found between samples from controls or uCD patients in any of the
molecules studied in both populations (Spanish and Argentinian). Similar results were also obtained
when Vα24-Jα18 and FoxP3 duodenal mRNA expression were independently analysed. Therefore,
both populations were merged to increase the sample size of uCD and C-control groups. The joint
analysis of both duodenal FoxP3 and Vα24-Jα18 mRNA levels allowed us to discriminate between
CD (treated and untreated), and non-CD samples (inﬂamed or non-inﬂamed) with a sensibility and
sensitivity of 92%, revealing a CD-like molecular proﬁle (C-controls: Spearman’s r = 0.3495, p < 0.05;
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I-controls: Spearman’s r = ´0.4577, p value = n.s; GFD-CD: Spearman’s r = ´0.4858, p < 0.05; uCD:
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Figure 2. Increased duodenal Vα24-Jα18 mRNA expression in untreated and treated celiac disease
patients. Expression levels of Vα24-Jα18 mRNA in duoden l biopsies indicated by the ratio
Vα24-Jα18/βactin in arbitrary units (AU), in untreated Celi c Disease (uCD), Gluten Free Diet-CD
patients (GFD-CD), inﬂamed non-CD controls (I-controls) and non-inﬂamed non-CD controls
(C-controls) in the Spanish population (A) and in uCD and C-controls in the Argentinian population
(B). Statistically signiﬁcant differences are shown (two tailed Mann-Whitney U test; Krustall-Wallis
test). Horizontal bars are median values. Correlation b tween the degre of histological l sion (Marsh
score) and the expression level of Vα24-Jα18 mRNA in C patients. (1: Marsh 0-I, 2: Marsh II,
3: Marsh IIIa, 4: Marsh IIIb, 5: Marsh IIIc) There was an increased of Vα24-Jα18 expression and the
duodenal increased level of atrophy (Spearman r = 0.063, p < 0.05). GFD-CD patients show a Marsh
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Figure 3. Correlation between duodenal mRNA expres ion of Vα24‐Jα18 and IFNγ. Expre si n levels 
of IFNγ mRNA in duodenal biop ies indicated as the  atio IFNγ/βactin, in arbitrary units (AU), in 
untr ated Celiac Disease (uCD), Gluten Free Diet‐CD patients (GFD‐CD), i flamed no ‐CD controls 
(I‐controls) and non‐i flamed non‐CD controls (C‐controls) in the Spanish population (A) and in uCD 
and C‐co trols in the Arg ntinian population (B). Statistically significant differences are shown (two 
tailed Mann‐Whitney U  test; Krustall‐Wallis  test). Horizontal bars are median  l s. Correlation 
between  the  expression  of  IFNγ  and  Vα24‐Jα18 mRNA,  in  arbitrary  units  (AU)  in  the  Spanish 
population  (C)  (C‐controls:  Spearman  r  =  0.3115,  p  value  =  n.s;  I‐controls:  Spearman  r  =  0.4265,   
p value = n.s; GFD‐CD: Spearman r = 0.5393, p value < 0.05; uCD: Spearman r = 0.4323, p value < 0.05) 
and  in  the  Argentinian  population  (D)  (C‐controls:  Spearman  r  =  0.5895,  p  value  <  0.05;  uCD: 
Spearman r = 0.6917, p value < 0.001). 
Figure 3. Correlation between duo enal mRNA ex ression of Vα24-Jα18 and IFNγ. Expression levels
of IFNγ mRNA in duodenal biopsies indicated as the ratio IFNγ/βactin, in arbitrary units (AU), in
untreated Celiac Disease (uCD), Gluten Free Diet-CD patients (GFD-CD), inﬂamed non-CD controls
(I-controls) and non-inﬂamed non-CD controls (C-controls) in the Spanish population (A) and in uCD
and C-con rols in the Arg ntinian popu ation (B). Statistical y signiﬁcant differ nces are shown (two
tailed Mann-Whitney U test; Krustall-Wallis test). Horizontal bars are median values. Correlation
between the expression of IFNγ and Vα24-Jα18 mRNA, in arbitrary units (AU) in the Spanish
population (C) (C-controls: Spearman r = 0.3115, p value = n.s; I-controls: Spearman r = 0.4265,
p value = n.s; GFD-CD: Spearman r = .5393, p value < 0.05; uCD: Spearman r = 0.4323, p value < 0.05)
and in the Argentinian population (D) (C-controls: Spearman r = 0.5895, p value < 0.05; uCD:
Spearman r = 0.6917, p value < 0.001).
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e l ﬁ Co relation betw en expre sion levels of FoxP3 and Vα24-Jα18 mRNA,
in arbitrary units (AU) (C-c ntrols: Spearman r = 0.3495, p value < 0.05; I-controls: Spearman
r = ´0.4577, p value = n.s; GFD-CD: Spearman r =´0.48 8, p value < 0.05; uCD: Spearman r =´0.056,
p value = n.s) (C).
All together, our ﬁndings suggest an increase of iNKT cells in the CD duodenum as determined
by molecular approaches. Therefore, we next studied the number of iNKT cells within the
intraepithelial and lamina propria compartments by ﬂow cytometry. To that end, the IEL proﬁle
was ﬁrst analyzed and compared with previous reports before determining the number of iNKT cells
in the CD duodenum.
3.4. Intraepithelial Lymphocytes in the Duodenum from Celiac iseas Patie t
Total IELs (CD103`CD45`), non-T cells (CD103`CD45`CD3´), TCRγδ` cells
(CD103`CD45`CD3`TCRγδ`) and TCRαβ` cells (CD103`CD45`CD3`TCRγδ´) were studied
within the intraepithelial compartment (as characterized in Figure 1A) given their relevance as
biomarkers in CD diagnosis [9,32].
Untreated CD patients had increased numbers of total IELs (median/IQR; 16.80%/4.80)
(Figure 5A,E) together with decreased numbers of non-T cells (3.10%/4.00) (Figure 5B,E). The latter
was also true in GFD-CD patients although the total number of IELs did not increase (GFD-CD,
10.40%/4.11) (Figure 5A,E). Within the CD3` subpopulation, both uCD and GFD-CD patients
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showed higher numbers of TCRγδ` cells (uCD, 35.78%/11.13; GFD-CD, 32.50%/8.90) (Figure 5C,E),
previously described as a distinctive feature of CD patients [9,32]. In support of this, inﬂamed non-CD
controls did not have increased numbers of TCRγδ` cells (I-controls, 7.51%/2.60) (Figure 5C,E)
despite the decreased percentage of non-T cells compared with non-inﬂamed non-CD controls
(I-controls, 16.30%/8.12; C-controls, 28.90%/15.75) (Figure 5B,E). However, these patients had
increased numbers of TCRαβ` cells (I-controls, 76.20%/8.20) compared with the remainder patient
groups (uCD, 59.30%/15.6; GFD-CD, 58.80%/10.90; C-controls, 62.10%/14.5) (Figure 5D,E).
Within the intraepithelial compartment, a decreased number of non-T cells together with
increased TCRγδ` cells represent a distinctive pattern of CD patients irrespectively of the disease
status [32,33]. Reference values of the IEL subpopulations for each patient’s group were expressed as
median percentages with the interquartile range (IQR) in Table 3.









Total IELs 16.80% (4.80) 10.40% (4.11) 10.70% (3.70) 8.50% (2.60)
Non-T cells 3.10% (4.00) 9.34% (3.34) 16.30% (8.12) 28.90% (15.75)
TCRγδ`cells 35.78% (11.13) 32.50% (8.90) 7.51% (2.60) 6.44% (2.38)
TCRαβ`cells 59.30% (15,6) 58.80% (10,9) 76.20% (8,9) 62.10% (14,5)
Percentages of duodenal Intraepithelial lymphocyte (IEL) populations in untreated Celiac Disease (uCD),
Gluten Free Diet-CD patients (GFD-CD), inﬂamed non-CD controls (I-controls) and non-inﬂamed non-CD
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GFD‐CD  patients  although  the  total  number  of  IELs  did  not  increase  (GFD‐CD,  10.40%/4.11)   
(Figure  5A,E). Within  the CD3+  subpopulation,  both  uCD  and GFD‐CD  patients  showed  higher 
numbers  of  TCRγδ+  cells  (uCD,  35.78%/11.13;  GFD‐CD,  32.50%/8.90)  (Figure  5C,E),  previously 
described as a distinctive feature of CD patients [9,32]. In support of this, inflamed non‐CD controls 
did not have  increased numbers of TCRγδ+ cells  (I‐controls, 7.51%/2.60)  (Figure 5C,E) despite  the 
decreased  percentage  of  non‐T  cells  compared  with  non‐inflamed  non‐CD  controls  (I‐controls, 
16.30%/8.12; C‐controls, 28.90%/15.75) (Figure 5B,E). However, these patients had increased numbers 
of  TCRαβ+  cells  (I‐controls,  76.20%/8.20)  compared  with  the  remainder  patient  groups  (uCD, 
59.30%/15.6; GFD‐CD, 58.80%/10.90; C‐controls, 62.1 %/14.5) (Figure 5D,E). 
Within  the  intraepithelial  compartment,  a  decreased  number  of  non‐T  cells  together  with 
increased TCRγδ+ cells  represent a distinctive pattern of CD patients  irrespectively of  the disease 












controls  (I‐controls) and non‐inflamed non‐CD controls  (C‐controls), analyzed by  flow cytometry: 
Percentage of total IELs (CD103+CD45+) referred to the total of epithelial cells (A). Percentage of non‐
T  cells  (CD103+CD45+CD3−)  (B),  Tγδ  cells  (CD103+CD45+CD3+TCRγδ+)  (C)  and  Tαβ  cells 
(CD103+CD45+CD3+TCRγδ−)  (D)  referred  to  the  total  of  IELs. Horizontal  bar  are median  values. 
Statistically significant differences are shown (two tailed Mann Whitney U test; p < 0.05). Representative 
















Total IELs  16.80% (4.80)  10.40% (4.11)  10.70% (3.70)  8.50% (2.60) 
Non‐T cells  3.10% (4.00)  9.34% (3.34)  16.30% (8.12)  28.90% (15.75) 
TCRγδ+cells  35.78% (11.13) 32.50% (8.90)  7.51% (2.60)  6.44% (2.38) 
TCRαβ+cells  59.30% (15,6)  58.80% (10,9)  76.20% (8,9)  62.10% (14,5) 
Percentages of duodenal  Intraepithelial  lymphocyte  (IEL) populations  in untreated Celiac Disease 
(uCD),  Gluten  Free  Diet‐CD  patients  (GFD‐CD),  inflamed  non‐CD  controls  (I‐controls)  and   
non‐inflamed non‐CD controls (C‐controls) expressed as median percentages with the interquartile 
range (IQR). 




Figure 5. Phenotype of intraepithelial lymphocytes in the duodenum from celiac patients. Phenotype
of IELs in untreated Celiac Disease (uCD), Gluten Free Diet-CD patients (GFD-CD), inﬂamed non-CD
controls (I-controls) and non-inﬂamed non-CD controls (C-controls), analyzed by ﬂow cytometry:
Percentage of total IELs (CD103`CD45`) referred to the total of epithelial cells (A). Percentage
of non-T cells (CD103`CD45`CD3´) (B), Tγδ cells (CD103`CD45`CD3`TCRγδ`) (C) and Tαβ
cells (CD103`CD45`CD3`TCRγδ´) (D) referred to the total of IELs. Horizontal bar are median
values. Statistically signiﬁcant differences are shown (two tailed Mann Whitney U test; p < 0.05).
Representative ﬂow cytometry analysis data of IEL subpopulations (Tγδ, Tαβ and non-T cells) in
uCD, GFD-CD, I-controls and C-controls (E).
After characterizing the duodenal IEL proﬁle in CD patients and controls, we ﬁnally assessed
whether the percentage of iNKT cells was increased in the CD duodenum, as suggested by
molecular studies.
3.5. Increased Intraepithelial iNKT Cells in Celiac Disease Patients and Correlation with Vα24-Jα18
mRNA Expression
As suggested by molecular studies (Figure 2A,B), iNKT cells (as characterized in Figure 1B)
were increased within the IEL compartment from CD patients (in both, uCD: 7.4%/3.9 and GFD-CD:
6.1%/5.7) comparedwith non-CD groups (C-controls: 1.9%/0.8 and I-controls: 2.9%/1.5) (Figure 6A).
There were also differences in the phenotype of intraepithelial iNKT cells since CD patients
had a higher proportion of C 4` iNKT cells (uCD: 82.9%/11.4, GFD-CD: 70.0%/10.5, I-controls:
51.8%/14.5, C-controls: 30.2%/15.1) (Figure 6B). However, the number of iNKT cells from the lamina
propria did not differ in number in any of the groups (Figure 6C).
As previously shown, the mRNA expression of Vα24-Jα18 was analyzed by qPCR in all of these
duodenal biopsies (Figure 2A). For that reason, we studied whether the increased Vα24-Jα18 mRNA
expression could be used as a marker of the increased number of intraepithelial iNKT cells found
by ﬂow cytometry (Figure 6A). As shown in Figure 6D, the percentage of iNKT cells correlated
with Vα24-Jα18 mRNA levels (C-controls: Spearman’s r = 0.8603, p < 0.001; I-controls: Spearman’s
r = ´0.9455, p < 0.001; GFD-CD: Spearman’s r = ´0.9297, p < 0.001; uCD: Spearman’s r = 0.8287,
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p = 0.001), which conﬁrms our ﬁndings, but also that the study of Vα24-Jα18 mRNA levels may be a
















Vα24‐Jα18  mRNA  levels  (C‐controls:  Spearman’s  r  =  0.8603,  p  <  0.001;  I‐controls:  Spearman’s   




Figure  6.  Increased  intraepithelial  iNKT  cells  in  celiac  disease  patients  and  correlation  with   
Vα24‐Jα18 mRNA  expression.  Percentage  of  iNKT  cells  (CD45+CD3+Vα24‐Jα18+)  among  the  total 
number  of  Intraepithelial  Lymphocytes  (IELs)  in  untreated  Celiac  Disease  (uCD),  Gluten  Free   
Diet‐CD  patients  (GFD‐CD),  inflamed  non‐CD  controls  (I‐controls)  and  non‐inflamed  non‐CD 
controls (C‐controls) (A). Percentage of Intraepithelial CD4+  iNKT cells among the total number of 
iNKT cells in aCD, GFD‐CD, I‐controls and C‐controls (B). Percentage of iNKT cells among the total 







i 6. Increased intraepithelial iNKT cells in celiac dise se patients and correlation with Vα24-Jα18
mRNA expression. Perc ntage of iNKT cells (CD45`CD3`Vα24-Jα18`) among the total number of
Intraepithelial Lymphocytes (IELs) in untreated Celiac Disease (uCD), Gluten Free iet-CD patients
(GFD-CD), inﬂamed non- controls (I-controls) and on-inﬂamed non-CD co trols (C-controls) (A).
Percentage of Intraepithelial CD4` iNKT cells among the total number of iNKT cells in aCD, GFD-CD,
I-controls and -controls (B). Percentage of iNKT cells among the total number of Lamina Propria
Ly phocytes (LPLs) in aCD, GFD-CD, I-controls and C controls (C). Horizontal bars are median
values. Statistically signiﬁcant differences are shown (two tailed Mann Whitney U test; p < 0.05).
Correlation between Vα24-Jα18 mRNA expression, in arbitrary units (AU) and the percentage of
iNKT cells among the total number of IELs in aCD, GFD-CD, I-controls and C controls (C-controls:
Spearman r = 0.8603, p value<0.001; I-controls: Spearman r = ´0.9455, p value < 0.0001; GFD-CD:
Spearman r = ´0.9297, p value < 0.0001; uCD: Spearman r = 0.8287, p value = 0.001) (D).
4. Discussion
Despite their low numbers, iNKT cells may have an essential role for the immune homeostasis in
the gastrointestinal tract [17,34]. Here, we studied intestinal iNKT cells in the context of celiac disease
by molecular and cellular approaches, and found higher numbers of both total and CD4` iNKT cells
in the intraepithelial compartment of CD patients. We also found a correlation between the mRNA
expression of Vα24-Jα18 and (i) the severity of the mucosal lesion, and (ii) the mRNA expression of
IFNγ. Finally, the mRNA expression of both Vα24-Jα18 and FoxP3 might deﬁne an mRNA CD-like
molecular proﬁle. Altogether our ﬁndings suggest that the number of duodenal intraepithelial iNKT
cells is increased in CD patients.
Invariant NKT cells have a key role in the mechanism of oral tolerance [26,34], and their hepatic
depletion leads to the inability of developing oral tolerance in a mouse model [35]. These cells
may have an effect in the development of tolerogenic dendritic cells, which are responsible for the
proliferation of regulatory T cells [13]. Because of the innate and adaptive features of these cells, and
the ability to produce high levels of IL-4 and IFNγ [17], a role for iNKT cells has been suggested
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in inﬂammatory bowel disease [36] and in CD [37]. Some studies have characterized circulating
numbers of iNKT cells in CD patients, often with contradictory results [21,37,38], but few have
reported the number of these cells in the duodenum [37,39,40].
Proﬁling IEL subpopulations has been used as a tool in the diagnostic work out of
CD [9,32,41,42]. Using ﬂow cytometry, a method previously validated by Camarero et al. [5,9], we
have found similar percentages of IEL subpopulations than previous reports using similar [9,32] and
different methods [43], therefore reassuring that we have successfully identiﬁed iNKT within IELs.
However, these results are opposed to those from Calleja et al. [39] who did not ﬁnd increased total
IELs, as it has been previously described [9]. Moreover, neither Calleja et al. [39] nor Dunne et al. [40]
found an increased numbers of iNKT cells in the intraepithelial compartment of CD patients using a
similar method. Unfortunately, the nature of these differences between the results reported by these
authors and our study remains elusive. However, our ﬁnding of a strong correlation between iNKT
cells within the intraepithelial compartment and tissue mRNA expression of Vα24-Jα18 conﬁrms a
higher density of iNKT cells in the CD duodenum.
A very interesting question is whether the increased numbers of iNKT cells found in the
intraepithelial compartment of these patients correlates with similar changes in the number of
circulating iNKT cells. However, the study of circulating iNKT cells was not the aim of this research
and hence blood samples had not been obtained from patients as we had performed in a previous
study [21]. Future analysis will address this issue including the characterization (e.g., homing proﬁle)
of circulating iNKT cells in CD patients.
Grose et al. consistently reported reduced numbers of intestinal iNKT cells in CD as determined
by qPCR [37,44] and by immunoﬂuorescence [37], although in the later study the authors did not
discriminate between intraepithelial and lamina propria cells [37]. However, we found increased
numbers of iNKT cells in the intraepithelial compartment, but not in the lamina propria. Our
ﬁndings were also correlated with mRNA expression levels of Vα24-Jα18 despite our qPCR results
are not in agreement with the former studies [37,44]. Such discrepancy might be explained because
duodenal Vα24-Jα18 mRNA expression varies between different populations. Our results have been
conﬁrmed in two different sets of samples from individuals from different continents. Besides, the
increased Vα24-Jα18 mRNA expression found in the duodenum of CD patients also correlated with
the percentage of intraepithelial iNKT cells by ﬂow cytometry, with the Marsh score for the severity
of the lesion, and with the mRNA expression of IFNγ, giving further consistency to our results. We
are aware that the expression of the TCR Vα24 chain is not exclusive of iNKT cells and therefore
we may be identifying other cell types (by ﬂow cytometry and qPCR).However, the analysis of the
Vα24-Jα18 molecule is more restrictive than Vβ11 [21,38]. In fact, the identiﬁcation of iNKT cells by
mRNA expression has been recently proposed as a more reliable alternative than the previously used
co-expression of CD3` and CD161`, because T cells (non-NKT) may induce CD161` expression after
activation [45]. Moreover, we have found a direct correlation between Vα24-Jα18 mRNA expression
and the total numbers of Vα24-Jα18` cells (representative of pure iNKT cells) in the intraepithelial
compartment as determined by ﬂow cytometry. Therefore, we are conﬁdent that Vα24-Jα18 mRNA
expression is representative of the total numbers of iNKT cells in the duodenal mucosa.
Intraepithelial lymphocytes are an heterogeneous population of T cells and non-T cells, mainly
composed of cytotoxic CD8` T cells, whose main role is the maintenance of the epithelial integrity
by eliminating stressed cells and promoting epithelial repair [6]. Some authors have tried to
identify the nature of non-T cells within the IEL compartment, which have been characterized as
mainly NK cells, but also T cell precursors [46,47]. Dysregulated activation and increased IEL
T cell numbers is a hallmark of CD and this is critically involved in epithelial cell destruction
and subsequent development of villous atrophy [7,10]. The mechanisms underlying the massive
expansion of IFNγ–producing intraepithelial cytotoxic T lymphocytes (CTLs) and the destruction
of the epithelial cells lining the small intestine of CD patients is the focus of current research.
Meresse et al. [10] reported an oligoclonal expansion of CTLs in CD that exhibits profound
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genetic reprogramming of NK cell functions. These CTLs expressed aberrant cytolytic NK
lineage receptors, such as NKG2C, NKp44, and NKp46, which associated with adaptor molecules
bearing immunoreceptor tyrosine-based activation motifs, induce ZAP-70 phosphorylation, cytokine
secretion, and proliferation independently of TCR signalling as well as downregulation of the TCR.
All of these features are characteristic of the iNKT population [48,49] though we cannot conclude that
they really perform these functions in the CD duodenum and are responsible of tissue damage in CD.
IFNγ is mainly produced by the gluten-speciﬁc Th1 cells and is essential in CD pathogenesis.
Recent studies also suggest that IELs are an important source of IFNγ, and the production of IFNγ
persists even after GFD [8]. Our results show a correlation between the increased mRNA expression
of IFNγ in CD patients (both treated and untreated) and the mRNA expression of Vα24-Jα18. These
results together with the correlation between the mRNA expression of Vα24-Jα18, theMarsh score for
the severity of themucosal lesion and the total number of intraepithelial iNKT cells might suggest that
the increased of IFNγ in the CD duodenummight be favoring an increased recruitment of iNKT cells.
However, this requires further studies, which may be difﬁcult to perform given the low number of
iNKT cells. At present, it is considered that the natural ligands of iNKT cells are glycolipids from the
cytoplasm of enterocytes, released to the extracellular matrix after apoptosis or necrosis [18,50,51],
favoured by an environment rich in IFNγ and IL-15 characteristic in CD [52,53], and IL-15 plays a
central role in the biological function of iNKT cells [54]. This proinﬂammatory environment may be
relevant for the increase and activation of intraepithelial iNKT cells which, in turn, may be also a
source of IFNγ.
We also studied FoxP3 mRNA expression as an indirect measurement of Treg and found a
lower expression in the CD duodenum. However, we were unable to identify T cells expressing
intracellular FoxP3 neither in the duodenal lamina propria nor in the intraepithelial compartment by
ﬂow cytometry (data not shown). A possible explanation might be that FoxP3 expression in humans
is transient, dependent on the environment and not restricted to T-cells with a Treg phenotype [55,56].
In addition, and opposed to murine models [57], there is evidence suggesting that FoxP3 can be also
expressed in cells without regulatory function, such as epithelial and tumor cells [58–60]. Therefore
it is likely that we were not identifying T cells expressing FoxP3 by qPCR but other non-T cell types
which have remained elusive by ﬂow cytometry. Nonetheless, a CD-like molecular proﬁle based on
the mRNA expression of Vα24-Jα18 and FoxP3, which is also observed in GFD-CD patients, might be
used as a useful diagnostic biomarker.
In conclusion, we have found an increased number of iNKT cells in the duodenum from both
uCD and GFD-CD patients, irrespective of the mucosal status. Increased mRNA levels of Vα24-Jα18
correlated with the severity of the mucosal lesion and with the mRNA levels of IFNγ. A CD-like
molecular proﬁle, deﬁned by an increased mRNA expression of Vα24-Jα18 together with a decreased
expression of FoxP3, may represent a pro-inﬂammatory signature of the CD duodenum.
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